Shaanxi Meibang Pharmaceutical Group Co Ltd
SSE:605033
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ping An Bank Co Ltd
SZSE:000001
|
CN |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (141.4), the stock would be worth ¥1.96 (91% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1 595.8 | ¥22.1 |
0%
|
| 3-Year Average | 141.4 | ¥1.96 |
-91%
|
| 5-Year Average | 42.4 | ¥0.59 |
-97%
|
| Industry Average | 38.3 | ¥0.53 |
-98%
|
| Country Average | 28.9 | ¥0.4 |
-98%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
S
|
Shaanxi Meibang Pharmaceutical Group Co Ltd
SSE:605033
|
3B CNY | 1 595.8 | 133.4 | |
| US |
|
Corteva Inc
NYSE:CTVA
|
53.6B USD | 19.1 | 48.7 | |
| CA |
|
Nutrien Ltd
TSX:NTR
|
47.7B CAD | 12.3 | 14.9 | |
| CN |
|
Qinghai Salt Lake Industry Co Ltd
SZSE:000792
|
188.9B CNY | 24.2 | 22.7 | |
| CL |
|
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
|
25.4B USD | 27.6 | 43.2 | |
| CN |
|
Zangge Mining Co Ltd
SZSE:000408
|
137.1B CNY | 81.3 | 29.3 | |
| US |
|
CF Industries Holdings Inc
NYSE:CF
|
18.6B USD | 8.5 | 12.8 | |
| NO |
|
Yara International ASA
OSE:YAR
|
136.8B NOK | 10 | 10.5 | |
| SA |
|
SABIC Agri-Nutrients Company SJSC
SAU:2020
|
53.8B SAR | 10 | 12.4 | |
| RU |
|
PhosAgro PAO
MOEX:PHOR
|
912.2B RUB | 6 | 7.9 | |
| CN |
|
Shandong Hualu-Hengsheng Chemical Co Ltd
SSE:600426
|
77.1B CNY | 18.6 | 23.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 16.6 |
| Median | 28.9 |
| 70th Percentile | 52.9 |
| Max | 49 021 |
Other Multiples
Shaanxi Meibang Pharmaceutical Group Co Ltd
Glance View
Shaanxi Meibang Pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of pesticide preparations. The company is headquartered in Xi'An, Shaanxi and currently employs 933 full-time employees. The company went IPO on 2021-09-16. The firm's products mainly include fungicides and pesticides. The fungicides include 80% dimethylmorpholine water dispersible granules, 27% chunleimycin bromonitrile wettable powder, 72% pyrazole ether ester combined water dispersible granules, 22% chunleimycin chlorobromoisocyanuric acid wettable powder, etc. The insecticides include 21% abamectin benzoate fenitrile suspension, 22% thiamethoxam beta cypermethrin suspension, 45% biphenyl hydrazide ethiconazole suspension, 20% fenitrile bifenthrin suspension, etc.
